| Followers | 843 |
| Posts | 122852 |
| Boards Moderated | 8 |
| Alias Born | 09/05/2002 |
Friday, March 19, 2004 11:31:39 AM
I have just read the entire message board. I have no position in MRX but I am short IMDC, which makes several varieties of collagen that I expect to be massacred by Restylane.
I noticed a misconception on this board, however, about Botox. Restylane does not compete with Botox! Botox is used almost exclusively on the upper portion of the face, while Restylane will be used almost exclusively on the lower portion, especially the nasolabial fold.
>> the abstracts from the amer soc of derm and other meetings suggest there is a quiet revolution going on. <<
Can you elaborate? T.i.a.
I noticed a misconception on this board, however, about Botox. Restylane does not compete with Botox! Botox is used almost exclusively on the upper portion of the face, while Restylane will be used almost exclusively on the lower portion, especially the nasolabial fold.
>> the abstracts from the amer soc of derm and other meetings suggest there is a quiet revolution going on. <<
Can you elaborate? T.i.a.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent MRX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:05:02 PM
- Form 13F-HR - Quarterly report filed by institutional managers, Holdings • Edgar (US Regulatory) • 04/02/2026 01:27:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 08:56:08 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 04/01/2026 06:45:26 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 04/01/2026 06:40:57 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 04/01/2026 06:29:03 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/31/2026 03:57:13 PM
- Form 424B2 - Prospectus [Rule 424(b)(2)] • Edgar (US Regulatory) • 03/30/2026 03:34:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/26/2026 12:18:14 PM
- Marex Group plc announces Q1 trading update and hosts Investor Day in New York • GlobeNewswire Inc. • 03/26/2026 12:00:00 PM
- Marex Group plc files its Annual Report on Form 20-F • GlobeNewswire Inc. • 03/25/2026 09:46:27 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/25/2026 09:15:32 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/25/2026 09:07:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:05:21 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:05:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 08:05:17 PM
